Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Praveenkumar Basavaraj"'
Autor:
Kai-Cheng Chan, Praveenkumar Basavaraj, Jui-Chen Tsai, Jonathan Viehoever, Bing-Yan Hsieh, Xin-Yu Li, Guan-Jhong Huang, Wen-Chin Huang
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 14, p 7857 (2024)
Androgen deprivation therapy (ADT) is the primary treatment for advanced prostate cancer (PCa). However, prolonged ADT inevitably results in therapy resistance with the emergence of the castration-resistant PCa phenotype (CRPC). Hence, there is an ur
Externí odkaz:
https://doaj.org/article/26d361ac06dc4825929df50987001125
Autor:
Praveenkumar Basavaraj, Po-Fan Hsieh, Wen-Ping Jiang, Da-Tian Bau, Guan-Jhong Huang, Wen-Chin Huang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 164, Iss , Pp 114948- (2023)
Prostate cancer (PCa) is the most prevalent men’s cancer in America and Western countries. No effective therapies are currently available for PCa aggressiveness, including castration-resistant progression (CRPC). This study aims at evaluation of th
Externí odkaz:
https://doaj.org/article/136986a26060453eb1f1223b33fa8918
Autor:
Praveenkumar Basavaraj, Phakkhathorn Ruangsai, Po-Fan Hsieh, Wen-Ping Jiang, Da-Tian Bau, Guan-Jhong Huang, Wen-Chin Huang
Publikováno v:
Life, Vol 12, Iss 11, p 1769 (2022)
Prostate cancer (PCa) is the most common cancer in men, and this has been mainly noticed in Western and Asian countries. The aggregations of PCa and castration-resistant PCa (CRPC) progression are the crucial causes in the mortality of patients witho
Externí odkaz:
https://doaj.org/article/05951963eda04ea99342f1cfcad6cc59
Autor:
Praveenkumar Basavaraj, Po Fan Hsieh, Shih-Yin Huang, Jin-Bin Wu, Wen-Chin Huang, Guan-Jhong Huang, Phakkhathorn Ruangsai, Wen-Ping Jiang
Publikováno v:
Phytomedicine : international journal of phytotherapy and phytopharmacology. 93
Background Castration-resistant prostate cancer (CRPC) is one of the main causes of male cancer mortality. There is currently no effective treatment to cure this deadly prostate cancer (PCa) progression. However, recent research showed that activatio
Autor:
Guan-Jhong Huang, Wen-Chin Huang, Po Fan Hsieh, Shih-Yin Huang, Praveenkumar Basavaraj, Jin-Bin Wu, Wen-Ping Jiang, Hui-Ya Ho
Publikováno v:
Cancers
Volume 12
Issue 4
Cancers, Vol 12, Iss 914, p 914 (2020)
Volume 12
Issue 4
Cancers, Vol 12, Iss 914, p 914 (2020)
Background: Prostate cancer (PCa) is the most prevalent malignancy diagnosed in men in Western countries. There is currently no effective therapy for advanced PCa aggressiveness, including castration-resistant progression. The aim of this study is to
Autor:
Po-Fan, Hsieh, Wen-Ping, Jiang, Shih-Yin, Huang, Praveenkumar, Basavaraj, Jin-Bin, Wu, Hui-Ya, Ho, Guan-Jhong, Huang, Wen-Chin, Huang
Publikováno v:
Cancers
Background: Prostate cancer (PCa) is the most prevalent malignancy diagnosed in men in Western countries. There is currently no effective therapy for advanced PCa aggressiveness, including castration-resistant progression. The aim of this study is to